Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Carcinoma, Hepatocellular 29Carcinoma, Renal Cell 17Liver Neoplasms 12Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Neoplasms 5Leukemia, Myeloid, Acute 5Kidney Neoplasms 5Neoplasm Metastasis 4Urinary Bladder Neoplasms 3Thyroid Neoplasms 3Prostatic Neoplasms 3Lung Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Colorectal Neoplasms 3Carcinoma 3Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Multiple Myeloma 2Breast Neoplasms, Male 2Blast Crisis 2Adenocarcinoma, Follicular 2Urethral Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Thyroid cancer, medullary 1

Interventions

omburtamab I-131 2WP 744 2Topotecan 2Temozolomide 2pembrolizumab 1lenvatinib 1gallium citrate 1Sorafenib 1Rituximab 1Pentetic Acid 1Gemcitabine 1Gallium-67 1Erlotinib Hydrochloride 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Meningeal Carcinomatosis × Sorafenib × Clear all
NCT00964743 2013-09-09

Depocyt® With Sorafenib in Neoplastic Meningitis

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Terminated
2 enrolled 6 charts
BreastCNS

Breast Neoplasms, Neurologic Manifestations, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡